Facebook
X
LinkedIn
ForwardUpdates in Hematology and Oncology: Global Perspectives 2026
This course will offer Live (in-person) attendance only
Course Directors: Tanios S. Bekaii-Saab, M.D., Stephen M. Ansell, M.D., Ph.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., and Mustapha Tehfe, M.D.
June 26 - 27, 2026 - Humaniti Hotel Montreal Autograph Collection - Montreal, Quebec, Canada
Join us for a dynamic and highly interactive educational symposium designed specifically for hematologists and medical oncologists who are at the forefront of cancer care. This premier meeting will spotlight cutting-edge treatment strategies and offers practical insights for integrating the latest evidence into everyday clinical practice.
Led by internationally recognized experts, our core sessions deliver actionable guidance on applying state-of-the-art therapies, while fostering meaningful dialogue around emerging research and evolving standards of care. Attendees benefit from rich opportunities to engage directly with faculty, ask questions, and explore real-world applications of practice-changing data.
Whether you're seeking to refine your approach or stay ahead of the curve, this symposium equips you with the tools and knowledge to elevate patient outcomes and enhance your clinical decision-making.
To see the course fee, please log in or create an account
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. | $799 |
| Allied Health, NP, PA, Retirees | $599 |
Target Audience
This course is tailored for physicians, resident fellows, and healthcare professionals around the world who are passionate about advancing their expertise in hematology and medical oncology.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe newly emerging hematology and medical oncology data and discuss their implications for clinical practice.
- Identify biomarker-based treatment approaches across key areas of hematology and medical oncology.
- Evaluate how biomarker-based approaches guide personalized treatment decisions.
- Review novel therapeutic strategies in hematology and medical oncology.
- Assess how novel therapeutic strategies may be applied in patient care.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Updates in Hematology and Oncology: Global Perspectives 2026 |
Humaniti Hotel Montreal Autograph Collection Montreal, Canada |
June 26-27, 2026 |
All Presentations Eastern Time |
Friday, June 26, 2026 | |
7:00 AM | Registration and Breakfast |
7:45 AM | Welcome Introductions |
8:00 AM | Updates in the management of Kidney Cancer Yousef Zakharia, M.D., Mayo Clinic Arizona |
8:15 AM | Updates in the management of Prostate Cancer Adam M. Kase, M.D., Mayo Clinic Florida |
8:30 AM | Updates in the management of Bladder Cancer Zineb Hamilou, M.D., University of Montreal |
8:45 AM | Q&A and Panel Discussion |
9:05 AM | Updates in the management of Early-Stage Colorectal Cancer Conor D. O'Donnell, M.B., B.Ch., B.A.O., Mayo Clinic Florida |
9:20 AM | Updates in the management of Advanced Colorectal Cancer Tanios S. Bekaii-Saab, M.D., Mayo Clinic Arizona |
9:35 AM | Q&A and Panel Discussion |
9:50 AM | Coffee Break and Exhibits |
10:10 AM | Updates in the management of Hepatobiliary Cancers Daniel H. Ahn, D.O., Mayo Clinic Arizona |
10:25 AM | Updates in the management of Pancreas Cancers Ben George, M.B.B.S., M.D., Mayo Clinic Rochester |
10:40 AM | Updates in the management of Gastro-Esophageal Cancer Mustapha Tehfe, M.D., M.Sc., University of Montreal |
10:55 AM | Q&A and Panel Discussion |
11:15 AM | Coffee Break and Exhibits |
11:25 AM | Updates in the management of Neuroendocrine Tumors Thor R. Halfdanarson, M.D., Mayo Clinic Rochester |
11:40 AM | Updates in the management Gynecologic cancers Andrea E. Wahner Hendrickson, M.D., Mayo Clinic Rochester |
12:00 PM | Q&A and Panel Discussion |
12:15 PM | Lunch |
1:15 PM | Updates in the management of Coagulation Disorders Meera Sridharan, M.D., Ph.D., Mayo Clinic Rochester |
1:40 PM | Updates in the management of Thrombotic Disorders Surbhi Shah, M.B.B.S., Mayo Clinic Arizona |
2:05 PM | Q&A Panel Discussion |
2:25 PM | Coffee Break and Exhibits |
2:40 PM | Updates in the management of Triple Negative Breast Cancer Pooja P. Advani, M.B.B.S., M.D., Mayo Clinic Florida |
3:00 PM | Updates in the management of Hormone Receptor Positive Breast Cancer Nathaniel Bouganim, M.D., McGill University Health Centre, Montreal |
3:20 PM | Updates in the management of HER2 positive Breast Cancer Roberto A. Leon-Ferre, M.D., Mayo Clinic Rochester |
3:40 PM | Q&A and Panel Discussion |
4:00 PM | Closing Remarks |
4:05 PM | Adjourn |
5:00 PM | Welcome Reception and Networking |
6:00 PM | ADJOURN – End of Day 1 |
Saturday, June 27, 2026 | |
7:30 AM | Registration and Breakfast |
8:15 AM | Welcome Introductions |
8:30 AM | Updates in the management Hodgkin Lymphoma Stephen M. Ansell, M.D., Ph.D., Mayo Clinic Rochester |
8:45 AM | Updates in the management Non-Hodgkin Lymphoma John Kuruvilla, M.D., FRCPC, University of Toronto |
9:05 AM | Updates in the management of Chronic Lymphocytic Leukemia Sameer A. Parikh, M.B.B.S., Mayo Clinic Rochester |
9:20 AM | Q&A and Panel Discussion |
9:40 AM | Updates in the management of Chronic Myelocytic Leukemia Pierre Villeneuve, University of Ottawa |
9:55 AM | Updates in the management of Myeloproliferative Neoplasms Naseema Gangat, M.B.B.S., Mayo Clinic Rochester |
10:10 AM | Q&A and Panel Discussion |
10:25 AM | Coffee Break and Exhibits |
10:45 AM | Updates in the management of Myelodysplastic Syndromes and Acute Myelocytic Leukemia James M. Foran, M.D., Mayo Clinic Florida |
11:05 AM | Updates in the management of Multiple Myeloma Rafael Fonseca, M.D., Mayo Clinic Arizona |
11:25 AM | Cellular Therapies for Cancer treatment Keith Stewart, M.B., Ch.B., University of Toronto |
11:45 AM | Q&A Panel Discussion |
12:05 PM | Lunch |
1:05 PM | Updates in the management of Advanced Stage Non-Small Cell Lung Cancer with Mutations Vamsi Velcheti, M.D., Mayo Clinic Florida |
1:25 PM | Updates in the management of Advanced Stage Non-Small Cell Lung Cancer without Mutations Aaron S. Mansfield, M.D., Mayo Clinic Rochester |
1:40 M | Q&A and Panel Discussion |
1:55 PM | Updates in the management of Early-Stage Non-Small Cell Lung Cancer Normand Blais, M.D., M.Sc., University of Montreal |
2:15 PM | Updates in the management of Small Cell Lung Cancer Rami Manochakian, M.D., Mayo Clinic Florida |
2:35 PM | Q&A and Panel Discussion |
2:50 PM | Closing Remarks |
3:00 PM | ADJOURN – End of Day 2 |
Steps from Palais des Congrès and downtown Montreal, Canada, Humaniti Hotel Montreal, Autograph Collection is an iconic building near Bell Center and local art galleries. Guests are minutes from some of the best speakeasies and secret bars in the city.
A block of rooms has been reserved for attendees at a group rate starting at $369 Canadian funds (CAD) per night, plus applicable fees and taxes. Make your reservations before the room block sells out or before the expiration date of June 2, 2026, whichever comes first. The discounted room reservation link will be included in the confirmation email after enrollment is complete.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 11.50 AMA PRA Category 1 Credit™
- 11.50 Attendance
This course offers the unique opportunity for commercial companies to interact with healthcare providers and highlight their products and services.
Further details coming soon.
Price
To see the course fee, please log in or create an account
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. | $799 |
| Allied Health, NP, PA, Retirees | $599 |
Please update your profile to let us know if you have dietary restrictions or access requirements.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.